Part 4 highlights how expanding epinephrine delivery options can reduce barriers, support earlier administration, and improve real-world anaphylaxis outcomes.
Jay Lieberman, MD
Advertisement
Jay Lieberman, MD, from the University of Tennessee
Articles by Jay Lieberman, MD
In this segment, experts emphasize the importance of giving an infant experiencing anaphylaxis epinephrine at whatever dose may be available rather than delaying treatment.
In the second part of the special report, panelists delink epinephrine use from mandatory emergency department visits.
In the opening segment of this special report, panelists discuss updated anaphylaxis guidelines and early management priorities.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Which children are most at risk for food allergy? New meta-analysis offers answers
2
Switching from dupilumab to upadacitinib improves skin clearance, itch in atopic dermatitis
3
Matthew Neidell, PhD, discusses community water fluoridation and birth outcomes
4
FDA issues CRL for RGX-121 gene therapy in mucopolysaccharidosis type II
5